파이프라인 | 적응증 | 개발 현황 | ||
---|---|---|---|---|
Hit
Lead
Candidate
Preclinical
Toxicity(GLP) Phase 1
|
||||
Tech 1. | OM-101 (Albumin-NO) |
Cancers |
|
|
Tech 2. | OM-201 (PNP-NO scavenger) |
Osteoarthritis |
|
|
OM-202 (NO scavenger) |
Autoimmune diseases (Rheumatoid & IBD) |
|
||
Tech 3. | OM-301 (mRNA delivery) |
PnP based DDS platform |
|